Oyster Peptides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis via Modulating the Gut Microbiota and Inhibiting the TLR4/NF-κB Pathway
Nutrients · 2024
DOI: 10.3390/nu16111591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Haixiang Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Animals, College of Animal Sciences, Jilin University, Changchun 130062, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Peptides, Signal Transduction. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Jilin Province.
Abstract (Originalsprache)
Ulcerative colitis (UC) is an inflammatory bowel disease with an increasing prevalence year over year, and the medications used to treat patients with UC clinically have severe side effects. Oyster peptides (OPs) have anti-inflammatory and antioxidant properties as functional foods that can alleviate a wide range of inflammatory conditions. However, the application of oyster peptides in ulcerative colitis is not well studied. In this work, an animal model of acute colitis was established using 3% dextran sulfate sodium (DSS), and the impact of OP therapy on colitis in mice was examined. Supplementing with OPs prevented DSS-induced colitis from worsening, reduced the expression of oxidative stress and inflammatory markers, and restored the intestinal barrier damage caused by DSS-induced colitis in mice. The 16S rDNA results showed that the OP treatment improved the gut microbiota structure of the UC mice, including increasing microbial diversity, increasing beneficial bacteria, and decreasing harmful bacteria. In the UC mice, the OP therapy decreased the relative abundance of Family_XIII_AD3011_group and Prevotella_9 and increased the relative abundance of Alistipes. In conclusion, OP treatment can inhibit the TLR4/NF-κB pathway and improve the intestinal microbiota in UC mice, which in turn alleviates DSS-induced colitis, providing a reference for the treatment of clinical UC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Animals, College of Animal Sciences, Jilin University, Changchun 130062, China.
- Department of Basic Medicine, Changzhi Medical College, Changzhi 046000, China.
ORCID-Profile: Bao Yuan
Förderung
- Department of Science and Technology of Jilin Province
Zitieren
APA
Guo, H., Xie, W., Ji, Z., Wang, B., Ren, W., Gao, W., & Yuan, B. (2024). Oyster Peptides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis via Modulating the Gut Microbiota and Inhibiting the TLR4/NF-κB Pathway. Nutrients. https://doi.org/10.3390/nu16111591
Vancouver
Guo H, Xie W, Ji Z, Wang B, Ren W, Gao W, et al. Oyster Peptides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis via Modulating the Gut Microbiota and Inhibiting the TLR4/NF-κB Pathway. Nutrients. 2024. doi:10.3390/nu16111591
BibTeX
@article{Guo2024,
author = {Guo, Haixiang and Xie, Wenyin and Ji, Zhonghao and Wang, Bingbing and Ren, Wenzhi and Gao, Wei and Yuan, Bao},
title = {Oyster Peptides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis via Modulating the Gut Microbiota and Inhibiting the TLR4/NF-κB Pathway},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16111591}
}
EUVIMED